# L-NMMA Dose-response Study in Healthy Subjects

> **NCT01070940** · PHASE1 · COMPLETED · sponsor: **Regional Hospital Holstebro** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NG-monomethyl-L-arginine (L-NMMA)
- **DRUG:** NG-monomethyl-L-arginine (L-NMMA)
- **DRUG:** NG-monomethyl-L-arginine (L-NMMA)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01070940
- **Lead sponsor:** Regional Hospital Holstebro
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01070940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01070940, "L-NMMA Dose-response Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01070940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*